Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Director | September 11, 2025 | September 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date September 11, 2025 · Filed September 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,994 |
Reported balance
After 2025-09-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-09-11 · Sale · Disposed 600 · Balance 1,994 F1: Includes 941 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 941 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2025 Filed Sep 11, 2025 20:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 600 | $81.71 | $49,026.00 |
DisclosureSEC source: 0000950170-25-114258 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,994 F1 · balance_after: Includes 941 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 20:30 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 400 | $78.01 | $31,204.00 |
DisclosureSEC source: 0000950170-25-086255 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,594 F1 · price: The price reported is weighted average price ($78.01). The shares were sold in multiple transactions at prices ranging from $77.99 to $78.03 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,882 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-075782 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,994 F1 · shares: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. F1 · balance_after: Includes 1,882 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, if she is a director of the Company on those dates. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 23:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,172 | $96.72 | $113,355.84 |
DisclosureSEC source: 0000950170-24-125740 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,112 F1 · price: The price reported ($96.72) is weighted average price. The shares were sold in multiple transactions at prices ranging from $96.68 to $96.81 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 712 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares in each of January 1, 2025 and April 1, 2025, if she is a director of the Company on those dates. Read SEC document |
| May 20, 2024 Filed May 21, 2024 21:47 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-063106 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,284 F1 · shares: Includes 1,424 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares on July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 20:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 500 | $107.89 | $53,945.00 |
DisclosureSEC source: 0000950170-24-031519 · ownership.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 860 F1 · balance_after: Includes 400 shares of restricted stock granted under the Company equity plans. Restrictions has lapse as to the 400 shares on April 1, 2024, subject to the grantee's continued service as director of Company on those dates. Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 20:32 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 240 | $105.81 | $25,394.40 |
DisclosureSEC source: 0001209191-23-046028 · doc4.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,360 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.72 to $106.28, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on October 1, 2023, January 1, 2024 and April 1, 2024, if she is a director of the Company on those dates. Read SEC document |
| May 16, 2023 Filed May 26, 2023 20:04 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032493 · doc4.xml · nonDerivative · entry 1 HAM NANCY · CIK 0001124500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2023, if she is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.